Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug ConjugateCancer ResearchNovember 14, 200810.1158/0008-5472.can-08-1776Cited by 1,678SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis